Source: Eur Respir J 2012; 39: 1290-1291
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Migliori Giovanni Battista, Dara Masoud, de Colombani Pierpaolo, Kluge Hans, Raviglione Mario C.. Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?. Eur Respir J 2012; 39: 1290-1291

Member's Comments

No comment yet.

Related content which might interest you: Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Drug-resistant tuberculosis in Europe Source: International Congress 2018 – Spanish and Portuguese Programme 2018: Part I Year: 2018 Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Extrapulmonary tuberculosis in Russia and in Europe Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis Year: 2010 Multidrug-resistant tuberculosis in the western region of Algeria Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Multidrug-resistant tuberculosis around the world: what progress has been made? Source: Eur Respir J 2015; 45: 150-160 Year: 2015 Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible? Source: Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017 Year: 2017 Resistance pattern for tuberculosis in Europe Source: Annual Congress 2009 - PG12 EU FP7 TB PAN-NET: Update in tuberculosis: advances in the management of drug resistant and multi-drug resistent tuberculosis cases Year: 2009 Multidrug resistance tuberculosis (MDR-TB) in the north east area of Tunisia Source: Eur Respir J 2007; 30: Suppl. 51, 700s Year: 2007 Our experience with multiple drug-resistant tuberculosis in Plovdiv Region, Bulgaria – 1999–2004 Source: Eur Respir J 2006; 28: Suppl. 50, 379s Year: 2006 Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities Source: Eur Respir J, 52 (4) 1800246; 10.1183/13993003.00246-2018 Year: 2018 Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Trends of multidrug-resistant tuberculosis clustering in Portugal Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018 Year: 2019 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Multidrug-resistant tuberculosis in children of Belarus Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021